Skip to main content
Premium Trial:

Request an Annual Quote

Sysmex, LabCorp Collaborate on Blood Testing for Personalized Medicine

NEW YORK (GenomeWeb) – Sysmex and Laboratory Corporation of America today announced a strategic collaboration to develop blood-based molecular diagnostic tests for personalized cancer care.

Under the terms of the agreement, Sysmex Inostics will provide reagents and services to allow Covance Drug Development, a LabCorp subsidiary, to perform so-called OncoBEAM and Plasma-Sequencing testing services to support clinical trials in oncology. Sysmex Inostics' OncoBEAM and Plasma-Seq assays allow researchers to perform genetic analysis of cell-free tumor DNA from blood samples. The two firms will also evaluate opportunities to develop commercial applications for the Sysmex technologies in clinical diagnostics.

The partnership brings together Sysmex Inostics' ability to develop diagnostic tests with LabCorp's existing involvement in clinical trials and ability to commercialize such tests, the firms said in a statement.

"This collaboration will allow us to expand Sysmex Inostics' testing services and products using LabCorp's worldwide network of central laboratory locations," Sysmex Chairman and CEO Hisashi Ietsugu said in a statement.

LabCorp acquired Covance in November 2014 for $6.1 billion.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.